Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
NCT Number: NCT01468779
The purpose of this study is to evaluate the effect of the probiotic use in patients with periampullary cancers undergone curative or palliative treatment considering nutritional status, postoperative complications, infection rate, length of hospitalization and mortality.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The probiotics pills are given orally in the amount of two pills twice a day as early as two days before surgery until ten days after surgery.
Time frame: participants will be followed for the duration of hospital stay, an expected average of 15 days
Death will be considered as the primary outcome related to complications of surgical treatment in postoperative period
Time frame: participants will be followed for the duration of hospital stay, an expected average of 15 days
To assess postoperative infection rate in patients submitted to periampullary cancer surgery using probiotics.
Hospital de Clinicas de Porto Alegre
Other
Effect of the Probiotics Use in Patients Undergoing Surgery for Periampullary Neoplasia - A Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.